Webinar - A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2

ABOUT THE EVENT

Date: Tuesday, October 21, 2025 9–9:45am EDT
Event Location: Virtual

Abstract

In their 2013 papers, Liang et al presented a large congeneric series of ligands aimed at exploring two areas of binding within the TYK2 active site: the first explored the hinge region while the second investigated the linker region1. A set of 16 ligands from the first paper is now commonly used as the TYK2 benchmark dataset to test the predictive abilities of FEP. Here we expand on the norm, showing the power of Free Energy Perturbation (FEP) in predicting unknown ligand binding affinities and importantly, how we would triage the results.

By presenting the FEP results from both the benchmark results and the blind production study, we will show you that Flare FEP can quickly provide valuable insights in drug discovery projects, such as the TYK2 example we discuss here.

A link to view the webinar on-demand will be sent out after the event for anyone who is unable to join the live session.

MORE EVENTS
Research teams around the world are focused on the power of mRNA. As mRNA continues to enter and be adopted by the global healthcare community, the need to quickly validate and scale these therapeutics becomes more critical. This discussion focuses on how sequencing-based insights can power AI-driven design and data-driven validation, helping to develop safe and effective drugs for treating and preventing disease.
Wednesday, October 22, 2025 12–1pm EDT
 · 
Virtual
The FDA is undergoing a major transformation in its drug approval processes, regulatory oversight and transparency initiatives. Join us for a live webinar exploring the implications of these reforms and what they mean for innovation, compliance and strategy in the biopharma industry.
Wednesday, November 5, 2025 11am–12pm EST
 · 
Virtual